Next |
home / stock / prfx / prfx message board
Subject | By | Source | When |
---|---|---|---|
In all honesty, I haven't a clue. I | subslover | investorshub | 05/01/2023 8:34:42 PM |
Whats the deal here? Seems like they have | Mr Rollup | investorshub | 05/01/2023 8:22:19 PM |
LMAO thats a good one! | subslover | investorshub | 05/01/2023 2:49:12 PM |
https://www.youtube.com/watch?v=4F4qzPbcFiA | TheFinalCD | investorshub | 05/01/2023 2:32:52 PM |
PainReform Announces Positive Safety Data in First Part | subslover | investorshub | 05/01/2023 1:24:13 PM |
Hi reena,nice to hear from you. Well I'm | subslover | investorshub | 03/14/2023 8:40:12 PM |
Hello strangers, You guys not trading any of | reena969 | investorshub | 03/14/2023 2:27:04 PM |
PainReform Announces Commencement of Phase 3 Clinical Trial | subslover | investorshub | 03/14/2023 12:27:48 PM |
oh yeah IF they traded and made $ | TheFinalCD | investorshub | 02/08/2023 5:14:49 PM |
Truth there, but congrats to those who got | herbied47 | investorshub | 02/08/2023 4:42:20 PM |
Just found out that it's all a P&D. | subslover | investorshub | 02/08/2023 4:11:54 PM |
Yikes | harry crumb | investorshub | 02/08/2023 12:35:04 PM |
what a sick world, where a delisting extension | TheFinalCD | investorshub | 02/08/2023 12:07:18 PM |
PainReform Ltd. (NASDAQ: PRFX) Announces Receipt of Extension | subslover | investorshub | 02/08/2023 9:35:08 AM |
Shorty is not going to have a good day. | trendzone | investorshub | 08/27/2021 11:54:45 AM |
Fentanyl Is Spreading Nationwide And Will Lead To | BottomBounce | investorshub | 07/29/2021 10:27:35 PM |
Big uptick the last half of the day, | trendzone | investorshub | 07/29/2021 9:51:23 PM |
Down 5th day in a row?? | Roadtojourney | investorshub | 07/28/2021 3:02:11 PM |
Was holding a huge bag and got out | stupidRICHxASAP | investorshub | 07/23/2021 3:30:27 PM |
Lol pure case of pump and dump?? | Roadtojourney | investorshub | 07/23/2021 3:23:52 PM |
News, Short Squeeze, Breakout and More Instantly...
PainReform Ltd. Company Name:
PRFX Stock Symbol:
NASDAQ Market:
Reaches 50% e nrollment in the s econd p art of its Phase 3 c linical t rial of PRF-110 in b unionectomy Remains on track to announce top-line data i n Q 3 202 4 TEL AVIV, Israel, May 15, 2024 (GLOBE N...
TEL AVIV, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (" PainReform " or the " Company "), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that Ilan Hadar, Chief Executive Officer o...
(NewsDirect) PainReform CEO Ilan Hadar joined Steve Darling from Proactive to discuss the company at the forefront of addressing the opioid crisis in the United States, is developing PRF-110, an innovative post-operative pain treatment designed as an alternative to traditional opioids. PR...